Skip to main content
. 2021 Apr 8;11:7706. doi: 10.1038/s41598-021-86994-6

Figure 3.

Figure 3

The spatial distribution of adverse outcomes of TB in Guizhou during 2013–2018. (a) Geographic distribution of rate of adverse reaction; (b) Geographic distribution of rate of lost to follow-up; (c) Geographic distribution of rate of treatment failed; (d) Geographic distribution of rate of died; (e) Geographic distribution of rate of switch to MDR.